Sean A. McCarthy - 16 Mar 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Issuer symbol
CTMX
Transactions as of
16 Mar 2023
Net transactions value
-$13,391
Form type
4
Filing time
20 Mar 2023, 18:43:33 UTC
Previous filing
06 Feb 2023
Next filing
23 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale $13,391 -7,121 -1.8% $1.88 388,821 16 Mar 2023 Direct F1, F2
holding CTMX Common Stock 93,158 16 Mar 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 161,250 restricted stock units.
F3 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.